Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5404185 | 0.98 | TSHR (0.46) | TSHRCA1CA9CA12CA2 | |
| SCHEMBL2964437 | 0.98 | TSHR (0.48) | TSHRCA1CA9CA12CA2 | |
| SCHEMBL28320390 | 0.83 | ALDH1A1 (0.52) | TSHRCA1CA9TDP1MEN1 | |
| SCHEMBL27828903 | 0.80 | TSHR (0.54) | TSHRTDP1LMNAKDM4EALDH1A1 | |
| SCHEMBL6553295 | 0.80 | TSHR (0.50) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| Fluoride SCHEMBL28135103 | 0.78 | TSHR (0.48) | TSHRMEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL28267649 | 0.78 | LMNA (0.55) | TSHRCA1CA9CA12CA2 | |
| SCHEMBL9770279 | 0.78 | TSHR (0.57) | TSHRCA1CA9CA12CA2 | |
| SCHEMBL9770256 | 0.78 | TSHR (0.57) | TSHRCA1CA9CA12CA2 | |
| SCHEMBL59256 | 0.78 | TSHR (0.57) | TSHRCA1CA9CA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138353-A1 | ABSORBENT ARTICLE WITH PATTERNED ACTIVE MATERIAL | ONTEX BV (BE) | 2026-05-21 | — | — | US | disclosed |
| WO-2023222737-A1 | ABSORBENT ARTICLE WITH PATTERNED ACTIVE MATERIAL | ONTEX BV (BE) | 2023-11-23 | — | — | WO | disclosed |
| EP-4279043-A1 | ABSORBENT ARTICLE WITH PATTERNED ACTIVE MATERIAL | Ontex BV (BE) | 2023-11-22 | — | — | EP | disclosed |
| CN-108431024-A | 3 type circovirus immunogenic composition of pig and its preparation and application | 堪萨斯州立大学研究基金会 | 2018-08-21 | — | — | CN | disclosed |
| US-9932687-B2 | High throughput screening of crystallization of materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-04-03 | — | — | US | disclosed |
| CN-107427572-A | The vaccine of new pig hepato-encephalomyelitis virus and diagnosis | 弗吉尼亚暨州立大学知识产权公司 | 2017-12-01 | — | — | CN | disclosed |
| US-9555150-B2 | Absorbent articles comprising an organic zinc salt and an anti-bacterial agent or alkali metal chloride or alkaline earth metal chloride | SCA HYGIENE PRODUCTS AB (SE) | 2017-01-31 | — | — | US | disclosed |
| US-20160184824-A1 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-06-30 | — | — | US | disclosed |
| US-9205423-B2 | High throughput screening of crystallization of materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-12-08 | — | — | US | disclosed |
| US-8709153-B2 | Microfludic protein crystallography techniques | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-04-29 | — | — | US | disclosed |
| EP-1212365-A2 | CRYSTAL STRUCTURES OF DOMAINS OF RECEPTOR PROTEIN TYROSINE KINASES AND THEIR LIGANDS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-0721773-B1 | Dental composition for relieving dentin hypersensitivity | SUN MEDICAL CO LTD (JP) | 2002-03-27 | — | — | EP | disclosed |
| WO-2001038393-A1 | POLYPEPTIDES DERIVED FROM VITAMIN D NUCLEAR RECEPTOR, AND THEIR USES IN PARTICULAR FOR SCREENING VITAMIN D ANALOGUES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2001-05-31 | — | — | WO | disclosed |
| WO-2001016181-A2 | CRYSTAL STRUCTURES OF DOMAINS OF RECEPTOR PROTEIN TYROSINE KINASES AND THEIR LIGANDS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (US) | 2001-03-08 | — | — | WO | disclosed |
| US-5879663-A | Dental composition for dentin hypersensitivity | SUN MEDICAL CO., LTD. (JP) | 1999-03-09 | — | — | US | disclosed |
| US-5766328-A | Dental composition for relieving dentin hypersensitivity | SUN MEDICAL CO., LTD. (JP) | 1998-06-16 | — | — | US | disclosed |
| EP-0744171-A1 | DENTAL COMPOSITION FOR HYPERSENSITIVE DENTIN | SUN MEDICAL CO., LTD. (JP) | 1996-11-27 | — | — | EP | disclosed |
| EP-0721773-A2 | Dental composition for relieving dentin hypersensitivity | SUN MEDICAL CO., LTD. (JP) | 1996-07-17 | — | — | EP | disclosed |
| WO-1990012565-A1 | WATER-CONTAINING FORMULATIONS WITH PHOSPHOLIPIDS | NATTERMANN, A. & CIE. GMBH (DE) | 1990-11-01 | — | — | WO | disclosed |
| US-4482759-A | Fungicidally active benzhydrol derivatives | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138353-A1 | ABSORBENT ARTICLE WITH PATTERNED ACTIVE MATERIAL | CUTA, AXIN2, CTNNA1 | TSHR 4824/4885CA1 574/4885CA9 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.